Postmarketing Studies: The Work of the Drug Safety Research Unit

被引：0
|
作者：
David J. Finney
机构：
来源：
Drug Safety | 1999年 / 21卷
关键词：
Adis International Limited; Thalidomide; Contractual Relation; Late Professor; Prescription Event Monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：337 / 338
页数：1
相关论文
共 50 条
  • [31] POSTMARKETING STUDIES OF DRUG EFFICACY - WHEN MUST THEY BE RANDOMIZED
    STROM, BL
    MIETTINEN, OS
    MELMON, KL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (01) : 1 - 7
  • [32] Analysis of Global Drug Development Pathways and Postmarketing Safety in Japan: Local Studies May Reduce Drug-Related Deaths
    Okubo, Tomoko Kawamura
    Ono, Shunsuke
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2019, 12 (04): : 408 - 415
  • [33] Research on the Unit of Work
    Cox, David
    Sharp, K. M. Dyce
    OCCUPATIONAL PSYCHOLOGY, 1951, 25 (02): : A90 - A108
  • [34] Does research synthesis have a place in drug regulatory policy? Synopsis of issues: Assessment of safety and postmarketing surveillance
    Anello, C
    ONeill, RT
    CLINICAL RESEARCH AND REGULATORY AFFAIRS, 1996, 13 (01) : 13 - 21
  • [35] Safety of Direct Oral Anticoagulants: Insights from Postmarketing Studies
    Villines, Todd C.
    Peacock, W. Frank
    AMERICAN JOURNAL OF MEDICINE, 2016, 129 (11): : S41 - S46
  • [36] Safety of direct oral anticoagulants: insights from postmarketing studies
    Villines, Todd C.
    Peacock, W. Frank
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (11): : 9 - 13
  • [37] Drug safety concerns focus attention on postmarketing surveillance, medication errors
    Wechsler, J
    FORMULARY, 1999, 34 (04) : 373 - 374
  • [38] Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies
    Lo Re, Vincent, III
    Haynes, Kevin
    Ming, Eileen E.
    Ives, Jennifer Wood
    Horne, Laura N.
    Fortier, Kimberly
    Carbonari, Dena M.
    Hennessy, Sean
    Cardillo, Serena
    Reese, Peter P.
    Reddy, K. Rajender
    Margolis, David
    Apter, Andrea
    Kimmel, Stephen E.
    Roy, Jason
    Freeman, Cristin P.
    Razzaghi, Hanieh
    Holick, Crystal N.
    Esposito, Daina B.
    Van Staa, Tjeerd-Pieter
    Bhullar, Harshvinder
    Strom, Brian L.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 (11) : 1202 - 1215
  • [39] Postmarketing surveillance for drug safety: Surely we can do better
    Griffin, MR
    Stein, CM
    Ray, WA
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (06) : 491 - 494
  • [40] Monitoring drug safety with registries: useful components of postmarketing pharmacovigilance systems
    Willis, Cameron D.
    McNeil, John J.
    Cameron, Peter A.
    Phillips, Louise E.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2012, 65 (02) : 121 - 125
12345